About us.

Bionical Emas is a Clinical Research Organisation (CRO) which combines Clinical Development, Early Access Program (EAP) and Clinical Trial Supply (CTS) services to deliver a unique, seamless approach to bring life-changing medicines around the world.

The Group deliver full clinical development services to global pharma and biotech companies. It’s integrated suite of services enables Bionical Emas to maximise access, collect data and generate evidence at every point along the drug development pathway.

Bionical Emas’ vision is to bring innovative life changing medicines to patients around the world through its unique business model and to pioneer the way treatments are developed and accessed by patients.

The Group’s strategy is to drive organic and acquisitive growth by developing and cross selling its widening portfolio of services and capabilities into its international client base and by expanding its geographical footprint.

It’s unique integrated business model, with a range of complementary services and capabilities, provides it with an entry point to become the preferred partner to many of the world’s leading Pharma and Biotech companies.

Bionical Emas runs global programs.

The Group employs 200 people and has offices in US, Europe, and Australia. It serves 10 of the top 25 pharma companies.

Develop. Access. Innovate

We are Bionical Emas.

At Bionical Emas we have an outstanding team of people who work together to bring life-changing medicines to patients around the world. The values that we share create a unique culture that guides us in everything that we do and establishes who we are.

We are bold
We are creative
We are flexible

We are proud of our people and proud of our achievements

We embrace

We champion a supportive and inclusive environment where everyone feels like they belong

We believe in
having fun on
the way

We build

We work as one team to consistently deliver excellence

We pioneer new approaches and are accountable for their delivery

We are driven by passion and understand that we change patient’s lives

We are changing what it is to be a
Clinical Research Organisation

Our accreditations.

Bionical Emas holds the following licences and certifications (copies of licences and certifications are available upon request).

MHRA Certificate of GDP Compliance of a Wholesale Distributor

Wholesale Distribution Authorisation (Human) (WDA (H) 36296)

Manufacturer’s “Specials” Licence (MS 36296)

Home Office Controlled Drug License

How can we support you?

Our dedicated teams of experts are on hand to help should you require any additional resource or further information about our services.

COVID-19 Guidance & Measures

A statement from the Bionical Emas Group on guidance & measures regarding COVID-19 - read here

In relation to staff and visitor safety, we have full risk assessments in place for all of our workplaces. These risk assessments are revisited and updated regularly, to reflect changing risks, knowledge and circumstances, and to reflect evolving Government guidance. We have not placed the risk assessments here on the website as they would become out of date too quickly. However, you are welcome to email info@bionical-emas.com to request access to our most up to date risk assessments applicable to your needs. Please note that all our staff are notified of all applicable risk assessments and updates, along with ‘quick guides’ automatically via our e-learning system.